Your browser doesn't support javascript.
loading
The relationship between weight change and inflammatory bowel disease. A population-based cohort study, the HUNT study.
Campo, Martin; Hjelle, Heidi; Granlund, Atle van Beelen; Sandvik, Arne Kristian; Ness-Jensen, Eivind.
Afiliação
  • Campo M; HUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway.
  • Hjelle H; HUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway.
  • Granlund AVB; Department of Medicine, Molde Hospital, Møre og Romsdal Hospital Trust, Molde, Norway.
  • Sandvik AK; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Ness-Jensen E; Department of Gastroenterology and Hepatology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Scand J Gastroenterol ; 59(7): 830-834, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38738865
ABSTRACT

BACKGROUND:

The incidence of inflammatory bowel disease (IBD) is increasing. The prevalence of overweight and obesity is increasing in parallel with IBD and could contribute to IBD development. The aim of this study was to assess the relationship between weight change and the risk for IBD.

METHODS:

Data gathered from 55,896 adult participants in the three first population-based Trøndelag Health Studies (HUNT1-3), Norway, performed in 1984-2008 was used. The exposure was change in body mass index between two HUNT studies. The outcome was a new IBD diagnosis recorded during a ten-year follow-up period after the exposure assessment. The risk of IBD by weight change was assessed by Cox regression analyses reporting hazard ratios (HRs) and 95% confidence intervals (CIs), adjusted for sex, age, and smoking status.

RESULTS:

There were 334 new cases of ulcerative colitis (UC) and 54 of Crohn's disease (CD). Weight loss decreased the risk of a new UC diagnosis by 38% (adjusted HR 0.62, 95% CI 0.39-0.97) and seemed to double the risk of getting a new CD diagnosis (adjusted HR 2.01, 95% CI 0.91-4.46). Weight gain was not associated with a new diagnosis of neither UC (adjusted HR 1.00, 95% CI 0.78-1.26) nor CD (adjusted HR 1.08, 95% CI 0.56-2.08).

CONCLUSION:

In this study, weight loss was associated with decreased risk of UC. However, no associations were seen between weight gain and the risk of UC or CD, suggesting that the increasing weight in the general population cannot explain the increasing incidence of IBD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aumento de Peso / Redução de Peso / Colite Ulcerativa / Doença de Crohn / Índice de Massa Corporal Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Scand J Gastroenterol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aumento de Peso / Redução de Peso / Colite Ulcerativa / Doença de Crohn / Índice de Massa Corporal Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Scand J Gastroenterol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Noruega